Characteristic | Annuloplasty without ring (De Vega procedure) (n = 34) | Annuloplasty with ring (n = 40) | P value | ||
---|---|---|---|---|---|
Age (yr ± SD) | 47.2 ± 7.3 | 49.5 ± 8.7 | 0.241 | ||
Male | 7 | 20.6 % | 4 | 10.0 % | 0.326 |
Preoperative NYHA ClassIII-IV | 33 | 97.1 % | 38 | 95.0 % | 0.945 |
Preoperative TI grade | |||||
None (n) | 0 | 0.0 % | 0 | 0.0 % | 0.131 |
Mild (n) | 8 | 23.5 % | 14 | 35.0 % | |
Moderate (n) | 18 | 52.9 % | 23 | 57.5 % | |
Severe (n) | 8 | 23.5 % | 3 | 7.5 % | |
Preoperative TS | 0 | 0 | 0 | 0 | |
Preoperative mitral valve disease | |||||
None (n) | 0 | 0.0 % | 0 | 0.0 % | 0.808 |
Stenosis (n) | 21 | 61.7 % | 24 | 60.0 % | |
Insufficiency (n) | 2 | 5.8 % | 4 | 10.0 % | |
Stenosis and insufficiency (n) | 11 | 32.4 % | 12 | 30.0 % | |
Preoperative aortic valve disease | |||||
None (n) | 17 | 50.0 % | 21 | 52.5 % | 0.98 |
Stenosis (n) | 1 | 2.9 % | 1 | 2.5 % | |
Insufficiency (n) | 7 | 20.6 % | 9 | 22.5 % | |
Stenosis and insufficiency (n) | 9 | 26.5 % | 9 | 22.5 % | |
Preoperative | |||||
LVEF | 55.9 ± 9.1 | 58.1 ± 7.1 | 0.253 | ||
RVD | 22.9 ± 5.1 | 21.9 ± 3.4 | 0.29 | ||
LVD | 49.6 ± 6.66 | 47.9 ± 8.8 | 0.351 | ||
PASP | 51.5 ± 16.6 | 49.9 ± 14.2 | 0.668 | ||
1 year Postoperative | |||||
LVEF | 61.9 ± 10.0 | 61.0 ± 8.8 | 0.733 | ||
RVD | 20.7 ± 2.9 | 20.0 ± 2.2 | 0.277 | ||
LVD | 44.5 ± 5.6 | 45.6 ± 4.1 | 0.37 | ||
PASP | 36.5 ± 7.4 | 36.0 ± 8.3 | 0.903 | ||
Concomitant procedures | |||||
MVR (n) | 22 | 64.7 % | 32 | 80.0 % | 0.132 |
AVR (n) | 0 | 0 | 0 | 0 | |
MVR + AVR (n) | 12 | 35.3 % | 8 | 20.0 % |